Author:
Vaidyanathan Sujata,Bartlett Michael,Dieterich Hans Armin,Yeh Ching-Ming,Antunes Ana,Howard Dan,Dole William P.
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference30 articles.
1. 1. Aliskiren. US Prescribing Information. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 2007.
2. Structure-based design of aliskiren, a novel orally effective renin inhibitor;Wood;Biochem Biophys Res Commun,2003
3. Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension;Oh;J Am Coll Cardiol,2007
4. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients;Gradman;Circulation,2005
5. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide;Villamil;J Hypertens,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献